Drug and Gene Delivery to the Central Nervous System for Neuroprotection Nanotechnological Advances /

This book summarizes the latest research on drug and gene delivery to the central nervous system (CNS). The chapters address safety concerns regarding the nanotechnology that is needed to develop nanomedicine for clinical practice. Particular focus is given to new technologies that have emerged in r...

Full description

Corporate Author: SpringerLink (Online service)
Other Authors: Sharma, Hari S. (Editor, http://id.loc.gov/vocabulary/relators/edt), Muresanu, Dafin F. (Editor, http://id.loc.gov/vocabulary/relators/edt), Sharma, Aruna. (Editor, http://id.loc.gov/vocabulary/relators/edt)
Language:English
Published: Cham : Springer International Publishing : Imprint: Springer, 2017.
Edition:1st ed. 2017.
Subjects:
Online Access:https://doi.org/10.1007/978-3-319-57696-1
LEADER 04274nam a22005175i 4500
001 978-3-319-57696-1
003 DE-He213
005 20210617051516.0
007 cr nn 008mamaa
008 170605s2017 gw | s |||| 0|eng d
020 |a 9783319576961  |9 978-3-319-57696-1 
024 7 |a 10.1007/978-3-319-57696-1  |2 doi 
050 4 |a RC321-580 
072 7 |a PSAN  |2 bicssc 
072 7 |a MED057000  |2 bisacsh 
072 7 |a PSAN  |2 thema 
082 0 4 |a 612.8  |2 23 
245 1 0 |a Drug and Gene Delivery to the Central Nervous System for Neuroprotection  |h [electronic resource] :  |b Nanotechnological Advances /  |c edited by Hari S. Sharma, Dafin F. Muresanu, Aruna Sharma. 
250 |a 1st ed. 2017. 
264 1 |a Cham :  |b Springer International Publishing :  |b Imprint: Springer,  |c 2017. 
300 |a XIII, 228 p. 47 illus., 38 illus. in color.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
505 0 |a Chapter 1 Renewable Biomaterials as Nanocarriers for Drug and Gene Delivery -- Chapter 2 Nanocarriers as CNS Drug Delivery Systems for Enhanced Neuroprotection -- Chapter 3 Nanotechnology Based Approaches for Neurodegenerative Disorders: Diagnosis and Treatment -- Chapter 4 Viral Vector Gene Delivery to the Brain for Treating Neurogenetic Diseases -- Chapter 5 Sleep Deprivation Induced Blood-Brain Barrier Breakdown and Brain Pathology. Neuroprotective Effects of Tio2-Nanowired Delivery of Cerebrolysin and Ondansetron -- Chapter 6 Glyco-Functionalised Biomaterials in Neuroregeneration -- Chapter 7 Targeting Nanoparticles to Brain: Impact of N-Methyl D-Aspartate Receptors. 
520 |a This book summarizes the latest research on drug and gene delivery to the central nervous system (CNS). The chapters address safety concerns regarding the nanotechnology that is needed to develop nanomedicine for clinical practice. Particular focus is given to new technologies that have emerged in recent years to deliver therapeutic materials, such as genes, drugs, and other agents using nanotechnologies of diverse origin. This is an ideal book for students, teachers, researchers, and clinicians interested in a deeper understanding of nanotechnological advances in therapeutic medicine. This book also: Broadens readers’ understanding of viral vector gene delivery to the brain for treating neurogenetic diseases as well as targeted gene delivery into the brain using microbubble-facilitated focused ultrasound Covers in detail the latest developments in delivering therapeutic materials, such as siRNA delivery to the brain for treating neurological diseases, neuroprotective effects of gelatin nanoparticles in stroke, and nanowired drug delivery for brain diseases, heat stroke, and CNS injury Enriches understanding of new technologies for delivering therapeutic materials treating Alzheimer’s Disease, including targeted nanodrug delivery through the blood-brain barrier and the superior neuroprotective effects of nanowired drug delivery in Alzheimer’s Disease. 
650 0 |a Neurosciences. 
650 0 |a Biomedical engineering. 
650 0 |a Neurobiology. 
650 1 4 |a Neurosciences.  |0 https://scigraph.springernature.com/ontologies/product-market-codes/B18006 
650 2 4 |a Biomedical Engineering and Bioengineering.  |0 https://scigraph.springernature.com/ontologies/product-market-codes/T2700X 
650 2 4 |a Neurobiology.  |0 https://scigraph.springernature.com/ontologies/product-market-codes/L25066 
700 1 |a Sharma, Hari S.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
700 1 |a Muresanu, Dafin F.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
700 1 |a Sharma, Aruna.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer Nature eBook 
776 0 8 |i Printed edition:  |z 9783319576954 
776 0 8 |i Printed edition:  |z 9783319576978 
776 0 8 |i Printed edition:  |z 9783319862262 
856 4 0 |u https://doi.org/10.1007/978-3-319-57696-1 
912 |a ZDB-2-SBL 
912 |a ZDB-2-SXB 
950 |a Biomedical and Life Sciences (SpringerNature-11642) 
950 |a Biomedical and Life Sciences (R0) (SpringerNature-43708)